Cabot Market Sentiment

Cabot Corp

CBTNYSE

Trade with Public

$74.29

-1.19-1.58%

마지막 업데이트: Oct 16, 4:00 PM

$74.29

-1.19-1.58%

Cabot Market Sentiment

Market sentiment signals for Cabot (CBT): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus— Neutral

Short Interest▲ 11.7% short float

Options Flow▼ 1.25 P/C ratio

Insider Activity— N/A

Analyst Consensus

Neutral

5 analysts

Options Flow (P/C)

1.25

More puts — Bearish

4 calls · 5 puts

Avg Consensus PT

$89

+20.3%

Highest Price Target

$98

+31.9%

Truist Securities

Lowest Price Target

$78

+5.0%

JP Morgan

Short Interest

11.7%

Declining — Bullish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 5, 2026	UBS	Joshua Spector—	+15.8%	$92 → $86	Maintained	Neutral
Aug 7, 2026	JP Morgan	Jeffrey Zekauskas—	+5.0%	$70 → $78	Maintained	Underweight
Aug 5, 2026	UBS	Joshua Spector—	+23.8%	$97 → $92	Maintained	Neutral
Jun 25, 2026	Mizuho	John Roberts—	+21.1%	$80 → $90	Maintained	Neutral
Jun 8, 2026	Truist Securities	Peter Osterland—	+31.9%	$98	Initiate	Buy
May 13, 2026	JP Morgan	Jeffrey Zekauskas—	-5.8%	$68 → $70	Maintained	Underweight
May 8, 2026	UBS	Joshua Spector—	+15.8%	$81 → $86	Maintained	Neutral
May 6, 2026	Mizuho	John Roberts—	+7.7%	$75 → $80	Maintained	Neutral
Feb 5, 2026	UBS	Joshua Spector—	+9.0%	$74 → $81	Maintained	Neutral
Feb 5, 2026	Mizuho	John Roberts—	+1.0%	$80 → $75	Downgrade	Outperform→Neutral
Jan 12, 2026	UBS	Joshua Spector—	-0.4%	$65 → $74	Maintained	Neutral
Dec 18, 2025	Mizuho	John Roberts—	+7.7%	$72 → $80	Maintained	Outperform
Nov 28, 2025	JP Morgan	Jeffrey Zekauskas—	-27.3%	$75 → $54	Maintained	Underweight
Nov 17, 2025	Mizuho	John Roberts—	-3.1%	$78 → $72	Maintained	Outperform
Nov 5, 2025	UBS	Joshua Spector—	-12.5%	$82 → $65	Maintained	Neutral
Oct 3, 2025	Mizuho	John Roberts—	+18.5%	$90 → $88	Maintained	Outperform
Aug 5, 2025	UBS	Joshua Spector—	+10.4%	$81 → $82	Maintained	Neutral
Apr 7, 2025	UBS	Joshua Spector—	+11.7%	$93 → $83	Maintained	Neutral
Feb 21, 2025	JP Morgan	Jeffrey Zekauskas—	+14.4%	$105 → $85	Maintained	Underweight
Jan 7, 2025	Mizuho	John Roberts—	+48.1%	$122 → $110	Maintained	Outperform
Nov 11, 2024	JP Morgan	Jeffrey Zekauskas—	+41.3%	$105 → $105	Downgrade	Neutral→Underweight
Nov 5, 2024	Mizuho	John Roberts—	+64.2%	$103 → $122	Maintained	Outperform
Aug 7, 2024	JP Morgan	Jeffrey Zekauskas—	+41.3%	$95 → $105	Maintained	Neutral
Aug 6, 2024	UBS	Joshua Spector—	+31.9%	$103 → $98	Maintained	Neutral
May 7, 2024	UBS	Joshua Spector—	+38.6%	$100 → $103	Maintained	Neutral

More with Benzinga EdgeGet Access

Insider & Market Activity News

Major Exercise Alert: Sean D Keohane Exercises Options Worth $4.41M At Cabot

A significant insider transaction involving the exercise of company stock options was reported on August 31, by Sean D Keohane, President and CEO at Cabot (NYSE:CBT), as per the latest SEC filing. What Happened:

Benzinga Insights

Cabot Insider Trades Send A Signal

Benzinga Insights

Notable Insider Move: Sean D Keohane Takes Part In Options Exercise At Cabot

Benzinga Insights

Major Update: Jeff Ji Zhu At Cabot Exercises Options, Making A Strategic Move

Benzinga Insights

Insider Decision Unfolding At Cabot: Erica McLaughlin Exercises Options

Benzinga Insights

Executive Vice President At Cabot Exercises Options Worth $952K

Benzinga Insights

Cabot Market Sentiment

Market sentiment signals for Cabot (CBT): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus— Neutral

Short Interest▲ 11.7% short float

Options Flow▼ 1.25 P/C ratio

Insider Activity— N/A

Analyst Consensus

Neutral

5 analysts

Options Flow (P/C)

1.25

More puts — Bearish

4 calls · 5 puts

Avg Consensus PT

$89

+20.3%

Highest Price Target

$98

+31.9%

Truist Securities

Lowest Price Target

$78

+5.0%

JP Morgan

Short Interest

11.7%

Declining — Bullish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 5, 2026	UBS	Joshua Spector—	+15.8%	$92 → $86	Maintained	Neutral
Aug 7, 2026	JP Morgan	Jeffrey Zekauskas—	+5.0%	$70 → $78	Maintained	Underweight
Aug 5, 2026	UBS	Joshua Spector—	+23.8%	$97 → $92	Maintained	Neutral
Jun 25, 2026	Mizuho	John Roberts—	+21.1%	$80 → $90	Maintained	Neutral
Jun 8, 2026	Truist Securities	Peter Osterland—	+31.9%	$98	Initiate	Buy
May 13, 2026	JP Morgan	Jeffrey Zekauskas—	-5.8%	$68 → $70	Maintained	Underweight
May 8, 2026	UBS	Joshua Spector—	+15.8%	$81 → $86	Maintained	Neutral
May 6, 2026	Mizuho	John Roberts—	+7.7%	$75 → $80	Maintained	Neutral
Feb 5, 2026	UBS	Joshua Spector—	+9.0%	$74 → $81	Maintained	Neutral
Feb 5, 2026	Mizuho	John Roberts—	+1.0%	$80 → $75	Downgrade	Outperform→Neutral
Jan 12, 2026	UBS	Joshua Spector—	-0.4%	$65 → $74	Maintained	Neutral
Dec 18, 2025	Mizuho	John Roberts—	+7.7%	$72 → $80	Maintained	Outperform
Nov 28, 2025	JP Morgan	Jeffrey Zekauskas—	-27.3%	$75 → $54	Maintained	Underweight
Nov 17, 2025	Mizuho	John Roberts—	-3.1%	$78 → $72	Maintained	Outperform
Nov 5, 2025	UBS	Joshua Spector—	-12.5%	$82 → $65	Maintained	Neutral
Oct 3, 2025	Mizuho	John Roberts—	+18.5%	$90 → $88	Maintained	Outperform
Aug 5, 2025	UBS	Joshua Spector—	+10.4%	$81 → $82	Maintained	Neutral
Apr 7, 2025	UBS	Joshua Spector—	+11.7%	$93 → $83	Maintained	Neutral
Feb 21, 2025	JP Morgan	Jeffrey Zekauskas—	+14.4%	$105 → $85	Maintained	Underweight
Jan 7, 2025	Mizuho	John Roberts—	+48.1%	$122 → $110	Maintained	Outperform
Nov 11, 2024	JP Morgan	Jeffrey Zekauskas—	+41.3%	$105 → $105	Downgrade	Neutral→Underweight
Nov 5, 2024	Mizuho	John Roberts—	+64.2%	$103 → $122	Maintained	Outperform
Aug 7, 2024	JP Morgan	Jeffrey Zekauskas—	+41.3%	$95 → $105	Maintained	Neutral
Aug 6, 2024	UBS	Joshua Spector—	+31.9%	$103 → $98	Maintained	Neutral
May 7, 2024	UBS	Joshua Spector—	+38.6%	$100 → $103	Maintained	Neutral